{"pmid":32489935,"pmcid":"PMC7242292","title":"Persistent viral shedding lasting over 60 days in a mild COVID-19 patient with ongoing positive SARS-CoV-2.","text":["Persistent viral shedding lasting over 60 days in a mild COVID-19 patient with ongoing positive SARS-CoV-2.","Quant Imaging Med Surg","Zhang, Lan","Li, Changbo","Zhou, Yanru","Wang, Binjie","Zhang, Jiajia","32489935"],"journal":"Quant Imaging Med Surg","authors":["Zhang, Lan","Li, Changbo","Zhou, Yanru","Wang, Binjie","Zhang, Jiajia"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489935","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.21037/qims.2020.04.08","topics":["Case Report"],"weight":1,"_version_":1668892169309519872,"score":9.490897,"similar":[{"pmid":32342849,"title":"Case Report: Viral Shedding for 60 Days in a Woman with Novel Coronavirus Disease (COVID-19).","text":["Case Report: Viral Shedding for 60 Days in a Woman with Novel Coronavirus Disease (COVID-19).","Novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has become a public health emergency of international concern. This was first noted in Wuhan, Hubei Province, China, and since then has become widespread globally. We report a 71-year-old woman with documented viral shedding (based on reverse transcription-polymerase chain reaction (RT-PCR) testing) of SARS-CoV-2 for 60 days from the onset of symptoms (55 days from her first positive test and 36 days after complete resolution of symptoms). This is to our knowledge the longest duration of viral shedding reported to date. This case demonstrates that viral shedding after COVID-19 diagnosis can be prolonged.","Am J Trop Med Hyg","Li, Junyao","Zhang, Lin","Liu, Baihui","Song, Debiao","32342849"],"abstract":["Novel coronavirus disease (COVID-19) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has become a public health emergency of international concern. This was first noted in Wuhan, Hubei Province, China, and since then has become widespread globally. We report a 71-year-old woman with documented viral shedding (based on reverse transcription-polymerase chain reaction (RT-PCR) testing) of SARS-CoV-2 for 60 days from the onset of symptoms (55 days from her first positive test and 36 days after complete resolution of symptoms). This is to our knowledge the longest duration of viral shedding reported to date. This case demonstrates that viral shedding after COVID-19 diagnosis can be prolonged."],"journal":"Am J Trop Med Hyg","authors":["Li, Junyao","Zhang, Lin","Liu, Baihui","Song, Debiao"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32342849","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.4269/ajtmh.20-0275","locations":["Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666138495776718849,"score":65.86637},{"pmid":32284613,"pmcid":"PMC7095102","title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.","text":["Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding.","We report epidemiological and clinical investigations on ten pediatric SARS-CoV-2 infection cases confirmed by real-time reverse transcription PCR assay of SARS-CoV-2 RNA. Symptoms in these cases were nonspecific and no children required respiratory support or intensive care. Chest X-rays lacked definite signs of pneumonia, a defining feature of the infection in adult cases. Notably, eight children persistently tested positive on rectal swabs even after nasopharyngeal testing was negative, raising the possibility of fecal-oral transmission.","Nat Med","Xu, Yi","Li, Xufang","Zhu, Bing","Liang, Huiying","Fang, Chunxiao","Gong, Yu","Guo, Qiaozhi","Sun, Xin","Zhao, Danyang","Shen, Jun","Zhang, Huayan","Liu, Hongsheng","Xia, Huimin","Tang, Jinling","Zhang, Kang","Gong, Sitang","32284613"],"abstract":["We report epidemiological and clinical investigations on ten pediatric SARS-CoV-2 infection cases confirmed by real-time reverse transcription PCR assay of SARS-CoV-2 RNA. Symptoms in these cases were nonspecific and no children required respiratory support or intensive care. Chest X-rays lacked definite signs of pneumonia, a defining feature of the infection in adult cases. Notably, eight children persistently tested positive on rectal swabs even after nasopharyngeal testing was negative, raising the possibility of fecal-oral transmission."],"journal":"Nat Med","authors":["Xu, Yi","Li, Xufang","Zhu, Bing","Liang, Huiying","Fang, Chunxiao","Gong, Yu","Guo, Qiaozhi","Sun, Xin","Zhao, Danyang","Shen, Jun","Zhang, Huayan","Liu, Hongsheng","Xia, Huimin","Tang, Jinling","Zhang, Kang","Gong, Sitang"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32284613","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1038/s41591-020-0817-4","link_comment_in":"32214231","topics":["Case Report"],"weight":1,"_version_":1666138491353825281,"score":52.65222},{"pmid":32330293,"title":"Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.","text":["Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.","As an emerging infectious disease, the clinical course and virological course of SARS-CoV-2 infection remain to be further investigated. In this case report, we described a case of SARS-CoV-2 infection with clinical course more than two months. This patient had recovered from the pneumonia after treatment. The viral RNA of throat swabs became negative and the viral specific antibodies were produced during recovery period. However, the viral RNA reappeared and additionally persisted in throat swabs for more than 40 days. In addition, the viral RNA was detected in multiple types of specimens with extremely high titers in the saliva. In conclusion, these findings indicate that SARS-CoV-2 can cause a long clinical course. The coexistence of viral RNA and viral specific antibodies may imply an immune evasion of SARAS-CoV-2 from host's immune system. This article is protected by copyright. All rights reserved.","J Med Virol","Yang, Jian-Rong","Deng, Dao-Ting","Wu, Nan","Yang, Bin","Li, Hong-Juan","Pan, Xiao-Ben","32330293"],"abstract":["As an emerging infectious disease, the clinical course and virological course of SARS-CoV-2 infection remain to be further investigated. In this case report, we described a case of SARS-CoV-2 infection with clinical course more than two months. This patient had recovered from the pneumonia after treatment. The viral RNA of throat swabs became negative and the viral specific antibodies were produced during recovery period. However, the viral RNA reappeared and additionally persisted in throat swabs for more than 40 days. In addition, the viral RNA was detected in multiple types of specimens with extremely high titers in the saliva. In conclusion, these findings indicate that SARS-CoV-2 can cause a long clinical course. The coexistence of viral RNA and viral specific antibodies may imply an immune evasion of SARAS-CoV-2 from host's immune system. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Yang, Jian-Rong","Deng, Dao-Ting","Wu, Nan","Yang, Bin","Li, Hong-Juan","Pan, Xiao-Ben"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330293","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25940","keywords":["coronavirus","sars-cov-2","saliva","virus shedding"],"topics":["Case Report"],"weight":1,"_version_":1666138494704025601,"score":50.616924},{"pmid":32330309,"title":"Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days.","text":["Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days.","Coronavirus disease 2019 (COVID-19), caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly around the world. Currently, the identification of this disease is mainly conducted by using nasopharyngeal swabs([1]) , but the presence of SARS-CoV-2 RNA in feces of COVID-19 patients indicates the possibility of transmission via fecal-oral route([2-4]) . This article is protected by copyright. All rights reserved.","J Med Virol","Jiang, Xuejun","Luo, Mei","Zou, Zhen","Wang, Xu","Chen, Chengzhi","Qiu, Jingfu","32330309"],"abstract":["Coronavirus disease 2019 (COVID-19), caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly around the world. Currently, the identification of this disease is mainly conducted by using nasopharyngeal swabs([1]) , but the presence of SARS-CoV-2 RNA in feces of COVID-19 patients indicates the possibility of transmission via fecal-oral route([2-4]) . This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Jiang, Xuejun","Luo, Mei","Zou, Zhen","Wang, Xu","Chen, Chengzhi","Qiu, Jingfu"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330309","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25941","topics":["Diagnosis","Transmission"],"weight":1,"_version_":1666138494540447744,"score":46.610992},{"pmid":32331982,"pmcid":"PMC7194913","title":"Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.","text":["Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.","An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1-10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding.","J Microbiol Immunol Infect","Cheng, Chien-Yu","Lee, Yu-Lin","Chen, Cheng-Pin","Lin, Yi-Chun","Liu, Chun-Eng","Liao, Chia-Hung","Cheng, Shu-Hsing","32331982"],"abstract":["An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir (LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1-10, indicating that LPV/r did not shorten the duration of SARS CoV-2 shedding."],"journal":"J Microbiol Immunol Infect","authors":["Cheng, Chien-Yu","Lee, Yu-Lin","Chen, Cheng-Pin","Lin, Yi-Chun","Liu, Chun-Eng","Liao, Chia-Hung","Cheng, Shu-Hsing"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32331982","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jmii.2020.03.032","keywords":["covid-19","lopinavir/ritonavir (lpv/r)","sars cov-2","shedding"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["lopinavir-ritonavir drug combination"],"topics":["Case Report"],"weight":1,"_version_":1666138493952196612,"score":45.250763}]}